Bristol sets baseline for profits post-Plavix
Posted by Reuters: Business News on March 4, 2010
NEW YORK (Reuters) – Bristol-Myers Squibb Co set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world’s second-bestselling drug.
